Hepatitis C D006526

Related MeSH Hierarchy (4)

Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » Hepatitis C

Diseases [C] » Infections [C01] » Virus Diseases » Hepatitis, Viral, Human » Hepatitis C

Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Flaviviridae Infections » Hepatitis C

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Viral, Human » Hepatitis C

Description

INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.   MeSH

Subtype Terms (1)

Hepatitis C, Chronic
248 drugs (102 approved, 146 experimental)



Organization Involved with Phase 4 Indications (255)

AESCA Pharma GmbH

Aga Khan University

Ahvaz Jundishapur University of Medical Sciences

AIDS Clinical Trials Group

Ain Shams University

Al Azhar University

Alexander von Humboldt Association

Alexandria University

American Research Corporation (ARC)

American University of Beirut

AmFAR

Arizona State University

Astellas

Badalona Hospital Germans Trias i Pujol

Baqiyatallah Medical Sciences University

Bausch Health Companies

Baylor University

Bristol-Myers Squibb

British University In Egypt

Cairo University

California HIV/AIDS Research Program

Canadian Institutes of Health Research (CIHR)

Cancer Research Network

Catholic University of Korea

Center For Hepatitis C, Atlanta, GA

Chang Gung University

Cheongju St. Mary's Hospital

Chiayi Christian Hospital

Chronic Liver Disease Foundation

Chugai

Chungnam National University

City of Hope National Medical Center

City of San Francisco

Clinical Pharmacology of Miami

Columbia University

Community Research Initiative of New England

Cornell University

Dalhousie University

Dankook University

Davita Clinical Research

Department of Veteran Affairs

DIAGSERA

Dimension Research

Dr. Axel Baumgarten, Berlin

Duke University

Emek Medical Center

Emory University

Eulji University

Ev. Krankenhaus Essen-Werden

Far Eastern Memorial Hospital

Federal University of Health Science of Porto Alegre

Federal University of Rio de Janeiro

FGK Clinical Research GmbH

Foo Yin Hospital

Fundacio Lluita Contra la SIDA

Fundacion SEIMC-GESIDA

Georgetown University

German Liver Foundation

Getz Pharma

Gottfried Wilhelm Leibniz Universität Hannover

Government of Canada

Government of France

Government of Maryland

Government of Mexico

Government of Nova Scotia

Government of Taiwan

Government of Thailand

Guilan University

Guilin University

Hai Phong Medical University

Hallym University

Hamadan University of Medical Science

Hannover Clinical Trial Center GmbH

Hanyang University

Harvard University

Helwan University

Hepatitis C Trust

Hospital Federal de Bonsucesso

Hospital Universitario Fundación Alcorcón

Hospital Universitario San Cecilio

Humanity & Health Research Centre

Icahn School of Medicine at Mount Sinai

Id Care

Ilsan Hospital

Indivior Inc.

Inha University

Inje University

InterMune

International Society for Infectious Diseases

Iranian Blood Transfusion Research Center

Isfahan University

Janssen Pharmaceutica NV

Johns Hopkins University

Johnson and Johnson

J. W. Goethe University

Kadmon

Kaiser Permanente

Kaohsiung Medical University

Karolinska Institute

Keimyung University

King Abdul-Aziz University

King Faisal Specialist Hospital

King Faisal University

Konkuk University

Konyang University

Korea University

Kyoto University

Kyungpook University

Kyushu University

Liver Institute of Virginia

Louisiana State University

Lund University

Maastricht University

Mansoura University

Mater Misericordiae University Hospital

Mayo Clinic

Medical University of South Carolina

Medical University of Vienna

Melbourne Health

Menoufia University

MinaPharm Pharmaceuticals

Monash University

National Cancer Institute (NCI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

National Taiwan University

New York Presbyterian Hospital

New York University

NORDynamIC Study Group

Norte Study Group

Northwestern University

Novartis

Oregon Health and Science University

Orlando Clinical Research Center

Oslo Metropolitan University

Oswaldo Cruz Foundation

Pacific Health Foundation

Paochien Hospital

Partners in Health

PEI Provincial Correction Centre

People's Liberation Army of China

Peter J. Ruane, M.D.

Pfizer

PharmEvo Pvt Ltd

Pontificia Universidad Catolica de Chile

Principal SIMS/Services hospital lahore

Pusan National University

Region Skane

Research Foundation for Mental Hygiene, Inc.

Riyadh Military Hospital

Roche

Rockefeller University

Rwanda Biomedical Center

Rwanda Military Hospital

Saarland University

Schering-Plough

SC Liver Research Consortium, LLC

Scripps

Seoul National University

Services Hospital, Lahore

Services Institute of Medical Sciences, Pakistan

Shahid Beheshti University of Medical Sciences

Skaraborg Hospital

Sociedad Andaluza de Enfermedades Infecciosas

Sodra Alvsborgs Hospital

Soonchunhyang University

Southern California Research Center

Stanford University

State University of New York

State University of New York, Syracuse

St. James's Hospital, Dublin

Sungkyunkwan University

Tabriz Medical University

Taichung Veterans General Hospital

Taipei Medical University

Tanta University

Taoyuan General Hospital

TEMPUS

The Geneva Foundation

The University of Texas, Dallas

Trinity College Dublin

Tropical Diseases Hospital, Ho Chi Minh City

T.R.U.E. Research Foundation

Tufts University

Tzu Chi University

Uddevalla Hospital

United States Army

Universidad Carlos III Madrid

University of Alabama, Birmingham

University of Barcelona

University of Bonn

University of Bristol

University of Calgary

University of California, Los Angeles

University of California, San Francisco

University of Cantabria

University of Chicago

University of Cincinnati

University of Colorado, Denver

University of Florida

University of Freiburg

University of Gothenburg

University of Hawaii

University of Kentucky

University of Leeds

University of London

University of Malaga

University of Manitoba

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Michigan

University of Montpellier

University of Nebraska

University of New South Wales

University of Nimes

University of Nottingham

University of Ottawa

University of Oxford

University of Padova

University of Padua

University of Pennsylvania

University of Pittsburgh

University of Roma La Sapienza

University of Rwanda

University of Sao Paulo

University of Seville

University of South Carolina

University of Southern California

University of Tabriz

University of Tehran

University of Texas at Houston

University of Texas, San Antonio

University of Toronto

University of Turin

University of Ulm

University of Ulsan

University of Valencia

University of Vermont

University of Vienna

University of Virginia

University of Washington

University of Western Ontario

Vertex

Viet Tiep General Hospital

ViiV Healthcare

Virginia Commonwealth University

Western Hospital, Footscray, Victoria. Australia

Wilhelminenspital der Stadt Wien

Yale University

Yassin Abdelghaffar Charity Center for Liver Disease and Research

Yassin Abdel Ghaffar Charity Center for Liver Disease and Research

Yeshiva University

Yonsei University

Organization Involved with Phase 3 Indications (158)

Organization Involved with Phase 2 Indications (134)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.